{"altmetric_id":234313,"counts":{"readers":{"mendeley":11,"citeulike":1,"connotea":0},"total":{"posts_count":1},"f1000":{"unique_users_count":1,"unique_users":["F1000Prime"],"posts_count":1}},"citation":{"abstract":"This phase II trial evaluated the safety and efficacy of yttrium-90 ((90)Y)-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma (MCL).","abstract_source":"pubmed","altmetric_jid":"4f6fa5e93cf058f610005a18","authors":["Michael Wang","Yasuhiro Oki","Barbara Pro","Jorge Enrique Romaguera","Maria Alma Rodriguez","Felipe Samaniego","Peter McLaughlin","Frederick Hagemeister","Sattva Neelapu","Amanda Copeland","Barry I. Samuels","Evelyne M. Loyer","Yuan Ji","Anas Younes"],"doi":"10.1200\/jco.2009.21.8545","first_seen_on":"2011-08-16T06:46:31+00:00","issns":["1527-7755","0732-183X"],"issue":"31","journal":"Journal of Clinical Oncology","last_mentioned_on":1259798400,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19770379"],"pmid":"19770379","pubdate":"2009-11-01T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.","type":"article","uri":"http:\/\/ascopubs.org\/doi\/10.1200\/JCO.2009.21.8545","volume":"27","mendeley_url":"http:\/\/www.mendeley.com\/research\/phase-ii-study-yttrium90ibritumomab-tiuxetan-patients-relapsed-refractory-mantle-cell-lymphoma"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":3627846,"mean":4.9453817817504,"rank":2017851,"this_scored_higher_than_pct":25,"this_scored_higher_than":934030,"rank_type":"exact","sample_size":3627846,"percentile":25},"similar_age_3m":{"total_number_of_other_articles":51717,"mean":4.7194569572279,"rank":22178,"this_scored_higher_than_pct":41,"this_scored_higher_than":21674,"rank_type":"exact","sample_size":51717,"percentile":41},"this_journal":{"total_number_of_other_articles":4898,"mean":8.1929467020625,"rank":3352,"this_scored_higher_than_pct":12,"this_scored_higher_than":618,"rank_type":"exact","sample_size":4898,"percentile":12},"similar_age_this_journal_3m":{"total_number_of_other_articles":47,"mean":4.1511739130435,"rank":23,"this_scored_higher_than_pct":19,"this_scored_higher_than":9,"rank_type":"exact","sample_size":47,"percentile":19}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":5,"Student  > Doctoral Student":2,"Other":2,"Lecturer > Senior Lecturer":2},"by_discipline":{"Medicine and Dentistry":10,"Psychology":1}}},"geo":{"mendeley":{"US":1}}},"posts":{"f1000":[{"title":"Recommended in F1000 Prime","url":"https:\/\/f1000.com\/prime\/1248959","license":"public","citation_ids":[234313],"posted_on":"2009-12-03T00:00:00+00:00","f1000_classes":["new_finding"],"f1000_score":"1"}]}}